Cubist Pharmaceuticals (CBST) 39.88 -0.67
Cubist Pharmaceuticals, Inc.
(CBST) 39.88 -0.67
(CBST) 39.88 -0.67
| Last Trade: | 39.87 | Day Range: | 39.63 - 40.43 |
| Trade Time: | 04:05PM | 52wk Range: | 28.82 - 44.95 |
| Prev. Close: | 40.54 | Market Cap: | 2.53B |
| Open: | 40.05 | Div Yield: | 0 |
| Volume: | 1053280 | PE: | |
| EPS: | 0.55 |
The Latest On CBST
The Definitive Biotech ETF Guide (IBB, XBI, FBT) 5/21/12 1:35pm
Top 10 Small Cap ETFs 5/15/12 2:48pm
Wedbush Raises PT on Cubist Pharmaceuticals to $55 1/20/12 4:19pm
Bank of America Reiterates Buy Rating on Cubist 1/11/12 10:22am
Jefferies Maintains Buy, $48 PT on Cubist Pharmaceuticals 1/10/12 8:37am
Top 10 Small Cap ETFs 5/15/12
Top 10 Small Cap ETFs 5/15/12
Trade CBST
NOW!
NOW!
Partner Headlines
Press Releases
Cubist Pharmaceuticals to Present at May Investor Conference 5/7/12 Business Wire
Cubist Pharmaceuticals Reports First Quarter 2012 Financial Results 4/18/12 Business Wire
Cubist Opens Expanded Research and Development Facility 3/16/12 Business Wire
Cubist Pharmaceuticals Appoints Jane Henney to Board of Directors 3/9/12 Business Wire
Cubist Pharmaceuticals to Present at February/March Investor Conferences 2/20/12 Business Wire
Cubist Pharmaceuticals Appoints Alison Lawton to Board of Directors 2/16/12 Business Wire
Cubist Receives CUBICIN Paragraph IV Notice Letter 2/9/12 Business Wire
Cubist Pharmaceuticals Reports 2011 Fourth Quarter and Full Year Financial Results 1/19/12 Business Wire
From Benzinga's Newsdesk
- 5:03 PM Kraft Sells 30-Year Bonds at 5% Coupon, Record Low -Bloomberg
- 05:02 PM TICC Announces Amended Dividend Reinvestment Plan
- 05:01 PM AptarGroup Will Acquire Stelmi Group for About $207M
- 05:00 PM MSCI Inc. Announces Appointment of New Chief Financial Officer
- 4:59 PM Allegheny Tech Files Automatic Mixed Securities Shelf
- 4:59 PM NCI Building Systems Reports Q2 EPS $(0.45) vs $(0.39) Est, Sales $250.2M vs $250.20M Est
- 4:53 PM Carlyle Seeks Investments from China State Bodies -Bloomberg
- 4:52 PM Fed's Rosengren Calls for More Easing; Doesn't See Employment Improvement, Sees Inflation Below 2% with Significant Downside Risks; Expects 2.3% Economic Growth This Year
- 04:49 PM Neo Material Shareholders Approve Molycorp Acquisition
- 4:46 PM Teva Begins Trading on NYSE
- 04:45 PM Triumph Group Says All Criminal Proceedings in MS Closed; Civil Actions Still Pending
- 4:42 PM Eagle Materials Files Automatic Mixed Securities Shelf
- 4:41 PM BioMarin Pharma Files Common Stock Shelf Registration
- 4:40 PM Applied Materials Entered Into Amendment, Extension to Credit
- 4:37 PM F5 Reports Resignation of EVP of Worldwide Sales, Names Feringa Successor
Brain Trust
- Copart, Inc: Bull or Bear?
- New Contract Signing Highlights Mattersight's Coaching Analytics
- Syntroleum Says It Defends Renewable Fuels Intellectual Property Rights
- Starwood to Redeem Its 6.25% Senior Notes Due 2013
- ETF Pair Trade From New Constructs (AAPL, XLK, FDN, PXN, AMZN)
- Biostar Pharmaceuticals Provides Update Regarding Gel Capsule Safety Issues
- Endologix Announces Public Offering of 2.7 Million Shares of Common Stock
- Amerigroup Receives Upgrade to Senior Debt Rating
- Stereotaxis Appoints William C. Mills III as Chairman of Board of Directors
- Tengion Announces 1-for-10 Reverse Stock Split
- Is Facebook Secretly Cloning the iPhone 5?
- Was IBM Smart to Ban Siri?
- David Einhorn's Greenlight Capital Letter to Investors Defends Apple, Doesn't Mention Herbalife
- 5 Small-Cap Short Ideas
- Earnings Scheduled For May 29
- Stocks to Watch for the All Things Digital Conference: AAPL, ORCL, P, LNKD, ZNGA
- James Altucher Article Sends Neonode Soaring
- Meat Glue Harbors Rogue Diseases, Government Fails to Intervene
- Social Media Chatter on Dell Around Its Earnings Report
- Opera Would Be "Another Stupid Acquisition" for Facebook, Says Analyst
